Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 02/22/24
End: 07/03/24
Due: 07/03/25
Phase: N/A
Priority: Normal
Start: 08/09/21
End: 10/12/21
Due: 10/12/22
Phase: N/A
Priority: Normal
Start: 01/26/23
End: 06/08/23
Due: 06/08/24
Phase: N/A
Priority: Normal
Start: 10/16/24
End: 11/08/24
Due: 11/08/25
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Drug-Drug Interaction of ASN51 With Fluvoxamine, Itraconazole and Paroxetine in Healthy Subjects | NCT06232109 | Asceneuron S.A. | user2@example.com | None | 2024-02-22 | 2024-07-03 | 2025-07-03 | - | - | 2025-07-14 |
| Positron Emission Tomography Study in Healthy Subjects to Determine the Relationship Between Plasma Concentration and Brain Target Occupancy of ASN51 | NCT06390098 | Asceneuron S.A. | user2@example.com | None | 2021-08-09 | 2021-10-12 | 2022-10-12 | - | - | 2025-07-14 |
| PET Study of Repeated ASN51 in Healthy Volunteers | NCT05725005 | Asceneuron S.A. | user2@example.com | None | 2023-01-26 | 2023-06-08 | 2024-06-08 | - | - | 2025-07-14 |
| Study of ASN51 in Adults With Early Alzheimer's Disease | NCT06677203 | Asceneuron S.A. | user2@example.com | None | 2024-10-16 | 2024-11-08 | 2025-11-08 | - | - | 2025-07-14 |